Expert Outlook: Innovid Through The Eyes Of 5 Analysts
Portfolio Pulse from Benzinga Insights
Over the past three months, 5 analysts have shared their evaluations of Innovid (NYSE:CTV), revealing a range of outlooks from bullish to bearish. The average 12-month price target has increased by 14.63% to $2.82. Analysts have maintained or raised their ratings, with the highest price target set at $3.00. Innovid has shown a solid revenue growth rate of 20.51%, but struggles with profitability and returns on equity and assets.
June 04, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Innovid (NYSE:CTV) has received mixed analyst ratings over the past three months, with a notable increase in the average 12-month price target by 14.63% to $2.82. Analysts have maintained or raised their ratings, indicating a positive shift in sentiment. However, the company faces challenges in profitability and returns on equity and assets despite solid revenue growth.
The increase in the average price target and the maintenance or raising of ratings by analysts suggest a positive short-term outlook for Innovid. However, the company's challenges in profitability and returns may temper this optimism.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100